Back to search
FDAFDA · Food and drugs·Recall number Z-2292-2025

Bartels ELISA Legionella Urinary Antigen. Model Number: B1029-440. In Vitro Diagnostic test kit for the presumptive diagnosis of past or current Legionnaires Disease.

Published August 20, 2025 · Recall initiated: July 22, 2025

Summary

FDA records medical device Class II recall Z-2292-2025, published August 20, 2025 and initiated July 22, 2025. Recalling firm: Trinity Biotech USA; Status: Ongoing; Reported quantity: 968 kits; Lot: Model Number: B1029-440. UDI-DI: 05391516744065. Lot Numbers: 065 and 066. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Potential for Bartels ELISA Legionella Urinary Antigen kit B1029-440 lot 065 and 066 to contain particulate matter.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Trinity Biotech USA
Distributor
Worldwide - US Nationwide distribution in the states of Maryland and Utah. The countries of France, Germany, Ireland, Israel, Kuwait, Latvia, UK.
Lot
Model Number: B1029-440. UDI-DI: 05391516744065. Lot Numbers: 065 and 066
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Bartels ELISA Legionella Urinary Antigen. Model Number: B1029-440. In Vitro Diagnostic test kit for the presumptive diagnosis of past or current Legionnaires Disease. recalled?

Yes. FDA published recall Z-2292-2025 on August 20, 2025. Reported hazard: Potential for Bartels ELISA Legionella Urinary Antigen kit B1029-440 lot 065 and 066 to contain particulate matter.

What should I do if I have this product?

Voluntary: Firm initiated · Letter